share_log

Chimerix | 8-K: Current report

Chimerix | 8-K: Current report

Chimerix | 8-K:重大事件
美股SEC公告 ·  2024/07/03 14:16

Moomoo AI 已提取核心訊息

On June 27, 2024, Chimerix received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The company has until December 24, 2024, to regain compliance by maintaining a minimum bid price of $1.00 for at least 10 consecutive business days.If Chimerix fails to meet this requirement, it may be eligible for an additional 180-day compliance period by transferring to The Nasdaq Capital Market, provided it meets other listing standards. The company intends to actively monitor its stock price and consider options to regain compliance. Failure to regain compliance could result in delisting from Nasdaq.The notification does not immediately affect Chimerix's listing or trading on The Nasdaq Global Market. The company will explore available options to address the situation, but there is no assurance of success in regaining compliance or maintaining other Nasdaq listing criteria.
On June 27, 2024, Chimerix received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The company has until December 24, 2024, to regain compliance by maintaining a minimum bid price of $1.00 for at least 10 consecutive business days.If Chimerix fails to meet this requirement, it may be eligible for an additional 180-day compliance period by transferring to The Nasdaq Capital Market, provided it meets other listing standards. The company intends to actively monitor its stock price and consider options to regain compliance. Failure to regain compliance could result in delisting from Nasdaq.The notification does not immediately affect Chimerix's listing or trading on The Nasdaq Global Market. The company will explore available options to address the situation, but there is no assurance of success in regaining compliance or maintaining other Nasdaq listing criteria.
2024年6月27日,Chimerix收到納斯達克的通知,指出未能滿足連續30個業務日每股最低買盤價格1.00美元的要求。公司必須在2024年12月24日之前,通過保持每股至少10個連續業務日的最低買盤價格1.00美元來恢復合規。如果Chimerix未能滿足該要求,且符合其他上市標準,則可能有資格通過轉到納斯達克資本市場獲得額外的180天合規期。公司打算積極監控其股價並考慮期權以恢復合規。未能恢復合規可能導致從納斯達克退市。該通知不會立即影響Chimerix在納斯達克全球貨幣市場的上市或交易。公司將探索可用選項以應對該情況,但不能確保成功恢復合規或維持其他納斯達克上市標準。
2024年6月27日,Chimerix收到納斯達克的通知,指出未能滿足連續30個業務日每股最低買盤價格1.00美元的要求。公司必須在2024年12月24日之前,通過保持每股至少10個連續業務日的最低買盤價格1.00美元來恢復合規。如果Chimerix未能滿足該要求,且符合其他上市標準,則可能有資格通過轉到納斯達克資本市場獲得額外的180天合規期。公司打算積極監控其股價並考慮期權以恢復合規。未能恢復合規可能導致從納斯達克退市。該通知不會立即影響Chimerix在納斯達克全球貨幣市場的上市或交易。公司將探索可用選項以應對該情況,但不能確保成功恢復合規或維持其他納斯達克上市標準。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息